Neil Chatterji
Stock Analyst at B. Riley Securities
(1.54)
# 3,324
Out of 4,944 analysts
19
Total ratings
23.53%
Success rate
2.51%
Average return
Main Sectors:
Stocks Rated by Neil Chatterji
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLPT ClearPoint Neuro | Maintains: Buy | $20 → $28 | $11.92 | +134.90% | 4 | Apr 25, 2025 | |
| OPRX OptimizeRx | Maintains: Buy | $17 → $13 | $17.32 | -24.94% | 3 | Dec 24, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $95 → $50 | $38.34 | +30.41% | 2 | Nov 9, 2023 | |
| ARAY Accuray | Reiterates: Buy | $7.5 | $1.49 | +403.36% | 1 | Oct 4, 2023 | |
| ZUMZ Zumiez | Maintains: Neutral | $15 → $18 | $15.99 | +12.57% | 2 | Sep 8, 2023 | |
| KRMD KORU Medical Systems | Initiates: Buy | $4.5 | $4.30 | +4.65% | 1 | Sep 7, 2023 | |
| HYPR Hyperfine | Maintains: Buy | $2.5 → $3.5 | $1.26 | +177.78% | 3 | Aug 15, 2023 | |
| STXS Stereotaxis | Maintains: Buy | $6 → $5.5 | $2.70 | +103.70% | 2 | Mar 6, 2023 | |
| BFLY Butterfly Network | Initiates: Buy | $9.5 | $1.42 | +569.01% | 1 | Oct 4, 2022 |
ClearPoint Neuro
Apr 25, 2025
Maintains: Buy
Price Target: $20 → $28
Current: $11.92
Upside: +134.90%
OptimizeRx
Dec 24, 2024
Maintains: Buy
Price Target: $17 → $13
Current: $17.32
Upside: -24.94%
Establishment Labs Holdings
Nov 9, 2023
Maintains: Buy
Price Target: $95 → $50
Current: $38.34
Upside: +30.41%
Accuray
Oct 4, 2023
Reiterates: Buy
Price Target: $7.5
Current: $1.49
Upside: +403.36%
Zumiez
Sep 8, 2023
Maintains: Neutral
Price Target: $15 → $18
Current: $15.99
Upside: +12.57%
KORU Medical Systems
Sep 7, 2023
Initiates: Buy
Price Target: $4.5
Current: $4.30
Upside: +4.65%
Hyperfine
Aug 15, 2023
Maintains: Buy
Price Target: $2.5 → $3.5
Current: $1.26
Upside: +177.78%
Stereotaxis
Mar 6, 2023
Maintains: Buy
Price Target: $6 → $5.5
Current: $2.70
Upside: +103.70%
Butterfly Network
Oct 4, 2022
Initiates: Buy
Price Target: $9.5
Current: $1.42
Upside: +569.01%